Composition
- Active ingredients
- PIMAVANSERIN TARTRATE EQ 34MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PIMAVANSERIN TARTRATE EQ 34MG BASE · CapsuleANDA214925-001 · Discontinued
- PIMAVANSERIN TARTRATE EQ 34MG BASE · CapsuleThis page
- PIMAVANSERIN TARTRATE EQ 10MG BASE · TabletANDA214502-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA214493.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Pimavanserin
- Active substance
- pimavanserin tartrate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Zydus
- Status
- Discontinued
- FDA approval
- 16 Jan 2024
- Application
- ANDA214493-001